Tilray Brands (TLRY) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Tilray Brands (TLRY) is Neutral.

The composite score behind that read is -0.18, weighing +0.06 of bullish evidence against -0.40 bearish.

Tilray Brands last closed at $3.54, -1.39% on the session.

Against the IVW growth benchmark the position is -2.19% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

20 graded predictions for TLRY so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

Tilray Brands is classified under Health Care / Pharmaceuticals, with a market capitalisation of $530.54M.

StockMap tracks Tilray Brands as the 76th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite Tilray Brands ranks 103rd of 151 in the group, against a group median of -0.08.